Injectable Bone Substitute - Bone matrix implant, synthetic
Access comprehensive regulatory information for Injectable Bone Substitute - Bone matrix implant, synthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Life Healthcare Pty Ltd, manufactured by Biomatlante SA ZA les Quatre Nations in France. The device registration started on December 01, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The Injectable Bone Substitute is intended for use to reconstruct bony voids or bone gaps of the skeletal system (e.g. extremities, spine and pelvis).